Pluristem Therapeutics Inc (PSTI)

[zzaatt]

quite the turnaround this morning from 1.13 to 1.25 nice!

Yes, but we do seem to have a pretty volatile biotech market, up and down then repeat. It's been pretty steady down for a while, it's time for it to start back up again, and I'm guessing that Pluristem (independently of news) will do the same.

What I'm looking at now is the continued corroboration of positive news from the clinic, from Dr.Winkler:

Taken together, we believe the Phase III study design greatly supports the likelihood of its success.”

Referring to:

1. reduction of postoperative stress
2. systemic effect of PLX-PAD:
--- increase of contralateral gluteal muscle force
--- pro-regenerative immunological changes